Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for OnKure Therapeutics, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
RC
Ra Capital Management, L.P.
|
4.0M | 8.01% | Unchanged | Q1 '26 | 0.2% | |
|
Shares held by quarter
Peak holding4.0M (Q1'26)
Change over 8 quarters+4.0M
Share of the company8.010%
|
||||||
|
BI
BVF Inc/il
|
3.2M | 6.48% | +1.3M (+63.5%) | Q1 '26 | 0.4% | |
|
Shares held by quarter
Peak holding3.2M (Q2'26)
Change over 8 quarters+3.2M
Share of the company6.480%
|
||||||
28 more super investors behind a free account
See every manager holding OnKure Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$5.06M | 1.1M | 2.22% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$2.2M | 483.1K | 0.97% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding OnKure Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LB
Len Blavatnik
5%+ holder
13D · 20.0%
|
9.1M | 18.21% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AI
Access Industries Management, LLC
5%+ holder
13D · 20.0%
|
9.1M | 18.21% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
13 more holders behind a free account
See every insider and 5%+ holder of OnKure Therapeutics, Inc..
Sign up freeLoading...